Colibri Heart Valve Spinoff Colorado Therapeutics to Triple Space With New Lease
Colorado Therapeutics LLC, a researcher and manufacturer of a soft-tissue repair technology used in hernia repair, has leased 33,600 square feet in the development, at 486 S. Pierce St. in Louisville.
Colorado Therapeutics was spun out of Colibri Heart Valve LLC and recently closed a $4.3 million funding round. Its new lease will triple its space and enable it to expand the commercial applications of its technology.
“When we received U.S. FDA clearance of our soft tissue technology for commercial use, we knew we needed a facility that could accommodate our specific manufacturing needs, provide room to grow and be representative of a world-class medical device company,” said Eric Schauble, vice president of corporate development for Colorado Therapeutics.
Colorado Therapeutics was spun out of Colibri Heart Valve LLC and recently closed a $4.3 million funding round. Its new lease will triple its space and enable it to expand the commercial applications of its technology.
“When we received U.S. FDA clearance of our soft tissue technology for commercial use, we knew we needed a facility that could accommodate our specific manufacturing needs, provide room to grow and be representative of a world-class medical device company,” said Eric Schauble, vice president of corporate development for Colorado Therapeutics.